Top Rated Bangalore Call Girls Richmond Circle ⟟ 8250192130 ⟟ Call Me For Gen...
World Market for Orphan Drugs - Kalorama Information
1. The World Market for
Orphan Drugs
Kalorama Information Presents
A Short Preview
2. MarketResearch.com provides market research solutions to business professionals
seeking to enhance their business goals. We provide a number of business intelligence
solutions, from individual market research reports from over 700 leading global
publishers, to Knowledge Centers where clients can discover deeper business insight
products into a topic over time. Or perhaps your business needs a much wider view across
multiple industries and topics, if so, our Profound solution allows you to select specific
parts (graphs, tables, charts or sections) from different market research reports.
Our Account Managers have in-depth knowledge of the publishers and the various types
of reports in their respective industries. They give you unbiased and qualitative insights on
which reports will best meet your needs.
To learn more about which Market Intelligence Solution might best fit your needs, contact
us for a complimentary Business Intelligence Assessment. One of our Account Managers
will get right back in touch with you.
About Us
3. About Kalorama Information
For more than 30 years, Kalorama Information has been a leading publisher of market
research in medical markets, including the biotechnology, diagnostics, healthcare, medical
device, and pharmaceutical industries. Our comprehensive, timely, quality research and
innovative approach to analysis and presentation of market intelligence have made
Kalorama Information a premier source of market information for top industry decision
makers.
Kalorama Information’s reports track medical market trends, survey market players, and
provide a comprehensive analysis of each market with both the vital market data and
cogent, plain-English interpretation and insight.
Our research is written by industry experts who offer insight on industry structure and
competitive landscape, technology assessment and penetration, and emerging products
and trends. Their analysis is based on both primary and secondary research as well as
years of professional expertise in their respective industries. In addition to analyzing
current and historical trends, our analysts predict where the market is headed over the
next five to ten years.
4. The World Market for Orphan Drugs
In recent years, there has been a substantial increase in the number of drugs available to treat rare
("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this
trend and provides estimates for the market opportunity in the U.S., Europe, Japan and globally. With
over 400 pages of market analysis and over 120 figures and tables, the report provides in-depth
coverage of key competitors and important trends and challenges for makers of orphan drug
treatments.
Osteoporosis, arthritis, Alzheimer’s, and Parkinson’s are major factors affecting quality of life. Mortality
from cancer, diabetes, liver and kidney diseases has been slow to change, offering significant areas for
research breakthroughs. Cancer, poorly served by traditional chemotherapies, is a major opportunity
for biotech firms because the investment compared to return can be favorable: the field has high
priority with regulatory authorities who are willing to give it fast track status on the basis of smaller
(and therefore cheaper) clinical trials (a few extra months of survival could be enough to win FDA
approval); the clinical community is highly concentrated; and the market size is often larger than the
approved indication because of a high off-label use (for other cancers). Infectious diseases, the third
most common cause of death in many geographic regions, highlight the pressing need for new
therapies with novel mechanisms of action to avoid growing issues affecting this industry including a
top area of concern—drug resistance.
5. World Orphan Drug Market 2007-2017
$0
$20,000
$40,000
$60,000
$80,000
$100,000
$120,000
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Revenues
(in
millions)
Year
Source: Kalorama Information
6. Orphan Drugs TOC Highlights
o U.S. Orphan Drugs
o E.U. Orphan Drugs
o Japan Orphan Drugs
o Competitor Trends and Practices
o Orphan Drug Industry Trends
o More Consumers Choosing Anti-Aging Skin Care Over Antioxidants
View Report
7. For More on this Report and Additional Research
Visit MarketResearch.com
Or call
1-800-298-5699